Naltrexone can affect libido and sexual desire, but the direction of that effect is not straightforward. Depending on the dose, duration of use, and the person’s baseline, naltrexone has been linked to both increased and decreased sexual interest. A single dose may heighten arousal and orgasm intensity in some men, while chronic daily use at standard addiction-treatment doses has been associated with reduced desire and other sexual side effects. This paradox runs through much of the research on naltrexone and sex, making the honest answer more nuanced than a simple yes or no.
How Blocking Opioid Receptors Reaches the Hormonal System
The body’s own opioids, endorphins and related molecules, act as a brake on the reproductive hormone chain. They suppress the release of gonadotropin-releasing hormone (GnRH) in the brain, which in turn keeps levels of luteinizing hormone (LH) and, downstream, testosterone from rising too high.1PubMed. Impact of the opioid system on the reproductive axis When naltrexone blocks opioid receptors, it lifts that brake. Research has shown that opioid antagonists increase GnRH secretion, which triggers a pulsatile release of LH and a rise in testosterone.2PubMed. Effect of opioid antagonists on sex hormone secretion
This hormonal bump has been confirmed in primate studies. In male rhesus monkeys, naltrexone at all tested doses caused a rapid, pronounced increase in both LH and testosterone, with LH rising within about 20 to 40 minutes and testosterone within an hour.3Pharmacology Biochemistry and Behavior. Naltrexone effects on pituitary and gonadal hormones in male and female rhesus monkeys The same study found that female monkeys did not show the same gonadotropin surge, hinting early on that sex differences in naltrexone’s hormonal effects are real and meaningful.
On paper, boosting testosterone sounds like a recipe for higher libido. But hormones are only one ingredient in sexual desire. What happens at the level of brain reward circuits, subjective arousal, and mood can easily override a modest testosterone nudge, and that is where the picture gets complicated.
What Happens at Standard Addiction-Treatment Doses
Most people encounter naltrexone at 50 mg per day, the dose approved for treating alcohol and opioid use disorders. At this dose, the drug’s effects on sexual function lean negative for a sizable minority of users. In a study comparing men receiving naltrexone maintenance for opioid dependence, about 47% reported reduced sexual desire, roughly 67% reported erectile difficulties, and 87% reported premature ejaculation.4PubMed. Sexual dysfunction among male patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence Those are high numbers, though this population had a history of opioid use that itself disrupts sexual function, making it hard to isolate naltrexone’s contribution from the lingering effects of prior drug exposure.
Real-world safety monitoring paints a consistent picture. An analysis of the FDA’s Adverse Event Reporting System identified decreased libido as one of the statistically notable signals among the roughly 28,700 reports associated with naltrexone.5PubMed. Mining and disproportionality analysis of adverse events signals for naltrexone based on real-world data from the FAERS database Adverse-event databases have well-known limitations. People who experience no side effects rarely file reports, and the reports cannot prove causation. But the signal for decreased libido was strong enough to flag alongside known side effects like depressed mood, sleep disturbance, and agitation.
The practical takeaway for someone starting naltrexone for addiction is that diminished sexual desire is a recognized possibility, particularly with daily use. Not everyone experiences it, but it is common enough to be worth discussing with a prescriber before starting treatment.
The Dose and Duration Paradox
One of the more surprising threads in the naltrexone literature is that its sexual effects can flip depending on dose and how long you take it. A 2025 review in Sexual Medicine Reviews summarized this neatly: low acute doses of naltrexone tend to increase the number of orgasms men achieve, while higher doses and chronic use diminish orgasm intensity, sexual arousal, and desire.6Sexual Medicine Reviews. Orgasms, sexual pleasure, and opioid reward mechanisms In other words, a single dose of naltrexone given in a lab setting can enhance certain measures of sexual response, but the same drug taken every day over weeks or months can dampen them.
Why would this happen? One leading explanation centers on how the brain’s reward system adapts. Opioid receptors are deeply involved in the pleasurable dimension of sex. Blocking them briefly may produce a kind of rebound, a temporary heightening of sensitivity as the system compensates. But sustained blockade could deplete the reward signal over time, stripping some of the pleasurable reinforcement out of sexual experience and, with it, the motivation to seek it. This is speculative, and researchers are still working out the details, but it fits the pattern visible across studies.
Animal models point toward the brain’s dopamine reward pathway as a key player. In sexually exhausted male rats (animals that have mated to the point of temporary disinterest), systemic naltrexone reversed the exhaustion and restored mating behavior. Experiments pinpointed mu-opioid receptors in the ventral tegmental area, a core dopamine-producing region, as the site where this reversal happens.7PubMed. The mesolimbic system participates in the naltrexone-induced reversal of sexual exhaustion So at least in the short term, blocking opioid input to the dopamine system seems to reawaken sexual motivation.
Effects on Arousal and Orgasm in Controlled Experiments
A handful of small experiments have measured naltrexone’s effects on sexual response under controlled conditions. In one study of healthy men given a single 50 mg dose of naltrexone or placebo before a masturbation session, those in the naltrexone group achieved significantly more orgasms (an average of about 3.4 versus 2.6 with placebo). At the first orgasm, both the intensity of arousal and the intensity of the orgasm itself were rated higher under naltrexone.8PubMed. Naltrexone-induced augmentation of sexual response in men That finding suggests the drug can acutely boost the physical experience of sex, at least in a laboratory setting.
But another randomized placebo-controlled experiment tells a different part of the story. When participants received the same 50 mg dose, naltrexone reduced self-reported sexual arousal throughout the sexual response cycle. Prolactin levels went up, and the normal prolactin spike after orgasm was blunted. Interestingly, objective physiological measures like heart rate or blood pressure did not change.9PubMed. The influence of opioid blockage on the sexual response cycle: A randomized placebo-controlled experiment with relevance for the treatment of Compulsive Sexual Behavior Disorder (CSBD) The researchers concluded that naltrexone has an acute negative effect on sexual arousal, even at a single dose.
How do you reconcile one study showing stronger orgasms and another showing weaker arousal? The studies measured different things: orgasm count and intensity versus subjective arousal ratings across the entire sexual cycle. It is entirely possible for a drug to dampen the warmth and buildup of arousal while simultaneously intensifying the reflex-like peak of orgasm. These are not the same physiological events, and they rely on partially different brain circuits. The practical upshot is that naltrexone’s sexual effects are not one-dimensional. It does not simply turn the dial up or down.
Erectile Function and Morning Erections
Early clinical interest in naltrexone and sex came from observations in men with erectile problems. In a study of men with impotence, naltrexone treatment led to a significant increase in the number of morning and spontaneous full erections per week.10PubMed. Endorphins in male impotence: evidence for naltrexone stimulation of erectile activity in patient therapy A separate pilot study in men with erectile dysfunction found that morning erections increased under naltrexone, but libido and the frequency of sexual intercourse were not significantly changed.11PubMed. Opiate antagonists in erectile dysfunction: a possible new treatment option? Results of a pilot study with naltrexone
This disconnect is worth pausing on. Morning erections are largely a physiological reflex tied to sleep architecture and vascular health, not to conscious desire. Naltrexone seems to help with the mechanical side of erectile function without necessarily stoking psychological interest in sex. For men whose primary complaint is physical difficulty rather than low desire, that distinction matters. It also reinforces the broader point that libido, arousal, erection, and orgasm are separable components of sexual response, and naltrexone does not act on all of them in the same direction.
Sex Differences and Women’s Hormonal Responses
Most of the sexual-response research on naltrexone has been conducted in men. What little data exists for women tells a different hormonal story. In the primate study mentioned earlier, female rhesus monkeys did not show the same gonadotropin and testosterone surge that males did.3Pharmacology Biochemistry and Behavior. Naltrexone effects on pituitary and gonadal hormones in male and female rhesus monkeys
In women with polycystic ovary syndrome (PCOS), who tend to have elevated androgens, long-term naltrexone treatment actually lowered free testosterone levels significantly over three and six months. LH showed a slight downward trend as well, though it did not reach statistical significance.12Fertility and Sterility. Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome For women with PCOS, that testosterone reduction was actually a therapeutic goal, since excess androgens drive many of the syndrome’s symptoms. But the finding highlights that naltrexone’s hormonal effects are not simply “testosterone goes up.” In a hormonal milieu already shifted by excess androgens, the drug’s influence on feedback loops can move things in the opposite direction from what you see in typical men.
Animal research in female rats found that naltrexone could facilitate sexual receptivity, but only at a specific dose (3 mg/kg worked, while 1 mg/kg and 5 mg/kg did not).13PubMed. Naltrexone facilitation of sexual receptivity in the rat This narrow dose-response window is a recurring theme in the naltrexone-and-sex literature and underscores why clinical experiences can vary so widely.
Naltrexone as a Treatment for Hypersexuality
The fact that naltrexone can dampen sexual desire and reward is not always a side effect. For people with compulsive sexual behavior disorder (CSBD), it is the point. Naltrexone is used off-label as a pharmacotherapy for hypersexuality and problematic paraphilias, and the evidence for this application, while still limited, is broadly positive.
A feasibility study of 20 men with CSBD found that naltrexone significantly reduced scores on standard measures of hypersexual behavior during treatment. However, once treatment stopped, symptoms tended to creep back up, suggesting the drug’s effects on compulsive sexual urges are maintained only as long as the opioid blockade continues.14The Journal of Sexual Medicine. Naltrexone in Compulsive Sexual Behavior Disorder: A Feasibility Study of Twenty Men A broader review covering case reports and two retrospective/prospective studies (totaling about 40 male patients) found that introducing naltrexone was typically followed by a decrease in symptom intensity and long-lasting remission in most patients, even when prior attempts with psychotherapy and antidepressants had failed.15PubMed Central. Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness
Case reports reinforce this pattern. One man treated with naltrexone at 50 mg per day for alcohol use disorder noticed that his compulsive sexual behavior also diminished, an effect he had not anticipated.16PubMed Central. Compulsive Sexual Behavior and Alcohol Use Disorder Treated With Naltrexone: A Case Report and Literature Review This dual benefit makes sense given that both alcohol craving and compulsive sexual behavior engage overlapping reward pathways, and blocking opioid receptors attenuates the rewarding quality of both.
The review in Sexual Medicine Reviews explicitly connected the two sides of the coin: naltrexone may reduce compulsive sexual behavior precisely because it diminishes the pleasure experienced at orgasm, weakening the reinforcement loop that drives compulsive patterns.6Sexual Medicine Reviews. Orgasms, sexual pleasure, and opioid reward mechanisms For someone experiencing genuinely distressing hypersexuality, this attenuation of pleasure is therapeutic. For someone with typical sexual desire, the same mechanism feels like a loss.
The Naltrexone-Bupropion Combination and Sexual Function
Naltrexone is also an ingredient in Contrave (naltrexone/bupropion sustained release), a combination medication approved for weight management. The sexual side-effect profile of the combination differs from naltrexone alone, partly because bupropion is a dopamine-norepinephrine reuptake inhibitor known for being one of the few antidepressants that does not typically impair sexual function, and in some cases improves it.
A study of obese participants found that those treated with naltrexone/bupropion plus a comprehensive lifestyle intervention showed significant improvements in sexual function scores compared to those receiving usual care alone. Among participants who met the criteria for sexual dysfunction at the start of the study, over half in the naltrexone/bupropion group no longer qualified as dysfunctional after 26 weeks, compared with only about 19% of those in the comparison group.17PubMed Central. Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion It is difficult to disentangle how much of this improvement came from the medication versus weight loss, improved self-image, or the lifestyle intervention itself. But the finding suggests that the combination does not generally worsen sexual function and may actively improve it in people dealing with obesity-related sexual difficulties. Bupropion’s pro-dopaminergic properties likely counterbalance some of naltrexone’s dampening effect on sexual reward.
Why Experiences Vary So Widely
If you search online forums, you will find wildly contradictory reports from naltrexone users. Some people notice no change in libido at all. Some report a flatness to desire that lifts once they stop the drug. A smaller number describe the opposite, heightened interest or improved erectile quality. Several factors explain this scatter.
The reason someone is taking naltrexone matters enormously. A person recovering from opioid addiction is experiencing a wholesale reorganization of their reward system. Their baseline sexual function was likely already suppressed by chronic opioid use, and naltrexone’s effects land on very different neurochemistry than they would in someone who has never used opioids. Similarly, a person taking naltrexone for alcohol cravings may find that reducing drinking itself improves sexual function, masking or outweighing any direct drug effect.
Dose is another variable. The standard 50 mg daily dose used for addiction treatment is a full opioid blockade. Low-dose naltrexone (LDN), typically in the 1 to 4.5 mg range, is used off-label for chronic pain and autoimmune conditions. At those doses, the opioid blockade is brief and partial, and some proponents claim LDN actually boosts libido. Rigorous data on LDN’s sexual effects are scarce, but the dose-response pattern observed across higher-dose studies suggests that the low end of the range is less likely to cause the dampening of desire seen at 50 mg.
Genetic variation may also play a role. The mu-opioid receptor gene (OPRM1) has a well-studied variant. The review on naltrexone for hypersexuality specifically investigated whether this genetic polymorphism influenced treatment response, and the researchers found that it may affect how strongly naltrexone modulates compulsive sexual behavior.15PubMed Central. Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness People who carry different versions of this gene may experience meaningfully different sexual side effects from the same dose.
Prolactin, the Overlooked Mediator
One hormonal change that receives less public attention than testosterone is naltrexone’s effect on prolactin. The placebo-controlled experiment measuring sexual response found that naltrexone raised baseline prolactin levels and blunted the normal prolactin spike that follows orgasm.9PubMed. The influence of opioid blockage on the sexual response cycle: A randomized placebo-controlled experiment with relevance for the treatment of Compulsive Sexual Behavior Disorder (CSBD) Prolactin is well known as a suppressor of sexual desire and arousal, and chronically elevated prolactin from any cause (whether a pituitary tumor, certain psychiatric medications, or another drug) is a recognized driver of low libido in both men and women.
If naltrexone consistently raises prolactin, even modestly, this could be a mechanism through which it suppresses desire independently of its effects on testosterone or reward signaling. The prolactin finding also helps explain why subjective arousal drops even as certain physical responses (like erection quality) hold steady or improve. Prolactin acts primarily on the motivational and psychological aspects of sex rather than on vascular mechanics. For someone trying to understand why they feel less interested in sex while on naltrexone even though “everything works fine physically,” elevated prolactin is a plausible piece of the puzzle.
Practical Considerations When Starting Naltrexone
If you are about to start naltrexone and are concerned about sexual side effects, a few things are worth keeping in mind. First, the most consistent reports of reduced libido come from daily use at 50 mg for addiction treatment, not from occasional or low-dose use. Second, the sexual side effects tend to emerge over weeks, not immediately. The acute effects of a single dose are, if anything, more likely to enhance certain aspects of sexual response than to dampen them. Third, the presence and severity of sexual side effects vary by individual in ways that current science cannot fully predict.
If you notice changes in desire after starting naltrexone, they are worth reporting to your prescriber, both because dose adjustments or alternative medications may be available, and because the change could reflect something other than the drug itself, such as mood shifts, the psychological adjustment to sobriety, or interactions with other medications. The injectable form (Vivitrol), given once monthly, produces different blood-level patterns than daily oral naltrexone, and some patients find one formulation tolerable where the other was not, though head-to-head comparisons specifically for sexual side effects are lacking.
For clinicians considering naltrexone for compulsive sexual behavior, the drug’s capacity to reduce sexual desire and dampen orgasmic reward is the therapeutic mechanism, not a complication. Monitoring should focus on whether the reduction in compulsive urges occurs without tipping into a level of sexual apathy that distresses the patient. The feasibility study of 20 men with CSBD showed symptom rebound after discontinuation, which means treatment duration and tapering strategy become important clinical questions.14The Journal of Sexual Medicine. Naltrexone in Compulsive Sexual Behavior Disorder: A Feasibility Study of Twenty Men